Literature DB >> 4936576

Effect of chemotherapy on the duration of diarrhoea, and on vibrio excretion by cholera patients.

T I Francis, E A Lewis, A B Oyediran, O A Okubadejo, D Montefiore, I I Onyewotu, I Mohammed, E A Ayoola, R Vincent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4936576

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN： 0022-5304


× No keyword cloud information.
  6 in total

1.  Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents.

Authors:  T Yamamoto; G B Nair; M J Albert; C C Parodi; Y Takeda
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

2.  Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.

Authors:  S K Bhattacharya; M K Bhattacharya; P Dutta; D Dutta; S P De; S N Sikdar; A Maitra; A Dutta; S C Pal
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.

Authors:  C V Sciortino; J A Johnson; A Hamad
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  In vitro susceptibility of El Tor and classical Vibrio cholerae strains to trimethoprim and sulfamethoxazole.

Authors:  R S Northrup; M A Doyle; J C Feeley
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

Review 5.  Antimicrobial drugs for treating cholera.

Authors:  Ya'ara Leibovici-Weissman; Ami Neuberger; Roni Bitterman; David Sinclair; Mohammed Abdus Salam; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2014-06-19

6.  Comparison between Single Dose Azithromycin and Six Doses, 3 Day Norfloxacin for Treatment of Cholera in Adult.

Authors:  M K Bhattacharya; S Kanungo; T Ramamurthy; K Rajendran; A Sinha; A Bhattacharya; B Sharma Sarkar
Journal:  Int J Biomed Sci       Date:  2014-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.